Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.
Lumen Bioscience has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Lumen Bioscience's investors include Bill & Melinda Gates Foundation, CARB-X, US Department of Energy, U.S. Department of Defense, WestRiver Group.
Lumen Bioscience is headquartered in Seattle, United States.
Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.
Lumen Bioscience is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lumen Bioscience — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/lumen-bioscience. Accessed October 16, 2026.
VCBacked. (2025). Lumen Bioscience — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/lumen-bioscience
{{cite web |title=Lumen Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/lumen-bioscience |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated